Andreas Ludwig KALCKER Patent for IV use of Chlorine Dioxide:
Patent #: WO2018185346A1
patents.google.com/patent/WO2018185346A1/en
After reading Andreas' above patent here's what I see as the basic breakdown of IV use. Note that the chlorine dioxide solution was made to be basically pH neutral through the addition of certain components - here is a quote from the patent regarding the pH:
"
Especially for injection and infusion solutions, it may be crucial to adjust the pH of the CDL to that of the blood within a range of approximately pH 7.3 - 7.5 to avoid any undesirable effects. For this purpose, a pH regulator, in particular a buffer system, can be added to the CDL. Suitable is a bicarbonate buffer or a phosphate buffer, e.g. PBS, viewed. Although studies in vitro have shown that for some applications a higher or lower pH of the CDL would be beneficial, injection and infusion solutions should focus on compatibility with blood pH."
So after adjusting the pH, here's basically how it was used with human volunteers with Lyme borreliosis:
- 500ml of 50 ppm dripped via IV at a rate of 3 drops per second administered every 4 days for 2 weeks (4 infusions total)
Results: All were cured
For malaria, a plasmodium:
- 200ml of 400 ppm. This was given twice in one day - each dose just 1 hour apart.
Results: All were cured
Other diseases for animals were mentioned in the patent too.
Maybe someone on the forum could do some experiments with baking soda (sodium bicarbonate) or something similar to determine how much is needed to be added to 1000 to 3000 ppm CDS solution to get it to become pH neutral and how much ppm is lost, if any. I'm sure that would be very helpful
May we all be well,
Scott McRae